Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
For Women With Chronic Migraine, Worse Anxiety and Sleep
11/22/2022
Anxiety, poor sleep, and pain catastrophizing are more common in women with migraine than in healthy women, according to a study published in The Journal of Headache and Pain.
Anxiety, poor sleep, and pain catastrophizing are more common in women with migraine than in healthy women, according to a study published in The Journal of Headache and Pain.
Anxiety, poor sleep, and pain...
11/22/2022
Neurology
News
Psychoactive Drug Schedule Classification Out of Sync With Psychiatrist Views
11/22/2022
Nonprescribed use of methamphetamine and alprazolam "more concerning" and less acceptable than nonprescribed use of psilocybin and ketamine.
Nonprescribed use of methamphetamine and alprazolam "more concerning" and less acceptable than nonprescribed use of psilocybin and ketamine.
Nonprescribed use of...
11/22/2022
Psych Congress Network
News
Key Gene in Alzheimer Disease Tied to Cholesterol Accumulation in the Brain
11/21/2022
The APOE4 gene, considered the strongest risk factor for Alzheimer disease (AD), alters the way cholesterol moves around the brain, which likely contributes to cognitive impairment associated with the disease.
The APOE4 gene, considered the strongest risk factor for Alzheimer disease (AD), alters the way cholesterol moves around the brain, which likely contributes to cognitive impairment associated with the disease.
The APOE4 gene, considered the...
11/21/2022
Psych Congress Network

Advertisement

News
ADHD Diagnosis May Not Benefit Adolescent Quality of Life
11/20/2022
A childhood diagnosis of ADHD may not improve quality of life in adolescence, suggest study findings published online in JAMA Network Open.
A childhood diagnosis of ADHD may not improve quality of life in adolescence, suggest study findings published online in JAMA Network Open.
A childhood diagnosis of ADHD...
11/20/2022
Psych Congress Network
News
Anxiety Disorders Associated With Worse Cognitive Function
11/16/2022
Younger patients and those with agoraphobia were particularly affected.
Younger patients and those with agoraphobia were particularly affected.
Younger patients and those with...
11/16/2022
Psych Congress Network
News
Odds of Second-Line Antidepressant Acceptance Vary With First-Line Treatment
11/16/2022
A medication switch within the same class as the first-line treatment had better odds of patient acceptance.
A medication switch within the same class as the first-line treatment had better odds of patient acceptance.
A medication switch within the...
11/16/2022
Psych Congress Network

Advertisement

News
Sleep Brainwave "Fingerprints" May Improve Understanding of Schizophrenia, Other Disorders
11/16/2022
A new approach for characterizing the activity of the brain during sleep has revealed potential biomarkers in the brain activity of people with schizophrenia, according to a published in Sleep.
A new approach for characterizing the activity of the brain during sleep has revealed potential biomarkers in the brain activity of people with schizophrenia, according to a published in Sleep.
A new approach for...
11/16/2022
Psych Congress Network
News
Tryptophan Lowered Without Tryptophan Catabolite Pathway Activation in MDD, BD
11/15/2022
Total and free tryptophan, as well as the tryptophan/competing amino-acids ratio, were lower in people with MDD and BD, according to findings recently published.
Total and free tryptophan, as well as the tryptophan/competing amino-acids ratio, were lower in people with MDD and BD, according to findings recently published.
Total and free tryptophan, as...
11/15/2022
Psych Congress Network
News
First Batches of Novel Oral Drug Targeting Suicidal Bipolar Depression Released
11/15/2022
First batches of D-cycloserine and lurasidone (NRX-101), a phase 3-ready investigational drug targeting suicidal bipolar depression, released.
First batches of D-cycloserine and lurasidone (NRX-101), a phase 3-ready investigational drug targeting suicidal bipolar depression, released.
First batches of D-cycloserine...
11/15/2022
Psych Congress Network

Advertisement

News
Antipsychotic Efficacy Declines in Women Aged 45 and Older
11/12/2022
Researchers surmise this is due to lower estrogen levels.
Researchers surmise this is due to lower estrogen levels.
Researchers surmise this is due...
11/12/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use